… About ProQR Therapeutics An innovative biotech company advancing … Axiomer RNA-editing platform technology. We are ProQR We are ProQR We are ProQR, a biotechnology company dedicated to …
… ProQR founding story When our CEO, Daniel A. de Boer, knew … his newborn son had an incurable rare disease, he founded ProQR to help people like his son. Learn more. A personal … a difference in the world. Daniel continues to motivate ProQRians to remind them of the company’s mission and to …
ProQR will focus exclusively on the development of the Axiomer® RNA editing technology platform across multiple therapeutic areas. This comes following feedback from the European Medicines Agency (EMA) related to ProQR’s sepofarsen for Leber Congenital Amaurosis type 10 (LCA10).
Pride month at ProQR is an opportunity to celebrate and thank all of the LGBT+ people in our communities, including our employees, scientists, and doctors that made our research possible.
… ProQR Therapeutics Virtual R&D Event 2023 ProQR will host a virtual R&D event on Wednesday, March 29, … under “Events” in the “Investors & Media” section of ProQR’s website at www.proqr.com/events . The presentation is …
